Endocyte (ECYT) Tops Q1 EPS by 5c

Endocyte (NASDAQ: ECYT) reported Q1 EPS of ($0.27), $0.05 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings
• Jefferies bullish on Deckers Outdoor, sees HOKA growth slowdown as oversold